Clinical Impact of Tumor-Infiltrating Lymphocytes for Survival in Stage II Colon Cancer.

The article discusses a study on the prognostic role of tumor-infiltrating lymphocytes (TILs) in stage 2 colon cancers. The study was participated by patients who were diagnosed with pathologic stage 2 colon cancer after curative resection for colon carcinoma at the Samsung Medical Center at Sungkyunkwan University. The study concluded that FOXP3-positive and CD45RO-positive TILs have independent prognostic significance that can provide an independent predictor for prognosis and help refine the selection of patient subgroups with unfavorable prognosis.